Our body has the immune system to heal itself and with the development of modern medical science, many  treatments have been developed. However, if infected with a virus or get disease, various complications or aftereffects may remain during the treatment process. Prevention is the best treatment that can be completely cured with little effort. WHONIZ Co., Ltd. has been developing products for personal hygiene and infectious disease prevention and expanding the supply chain around the world.

The disease can be treated promptly with an early, prompt and accurate diagnosis and appropriate prescription.

Prompt and accurate diagnosis is a key factor in determining how to treat a patient. During the COVID-19 pandemic, we have come to realize that slowing down the spread of the virus through rapid and accurate diagnosis and tracking at an early stage is a key factor in suppressing the viral infection before therapeutic applications and vaccination. WHONIZ takes the lead in developing diagnostic technologies through new approaches in various fields such as Antibody Engineering, Bioinformatics, and Immuno-Genomics to establish a fast, simple, inexpensive and accurate diagnosis method for various viral infectious diseases.

We will bring a revolutionary paradigm shift in the medical industry by developing and providing new therapeutics using antibodies from OMR in Japan.

OMR has established an innovative antibody production technology that utilizes the characteristics of metastatic cancer cells, enabling to produce antibody against multi-cellular membrane-penetrating target molecules that have been difficult. Using OMR’s monoclonal antibodies, WHONIZ will develop and supply treatments for cancer types that have been difficult to treat (drug-resistant cancer, immunological escaping and cancer stem cells, etc.) and refractory autoimmune diseases, bringing about an innovative paradigm shift in the medical industry.